𝔖 Bobbio Scriptorium

✦ LIBER ✦

152 HIV-infected Hu-PBMC-SCID mice as a model for antiviral drug development: Michael A. Ussery, Dennis D. Broud, Owen L. Wood, and Paul L. Black. Division of Antiviral Drug Products, FDA, Rockville, MD

Book ID: 118393597
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 76 KB
Volume: 23
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(94)90275-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

151 Use of fluorescent tracking dye PKH2

151 Use of fluorescent tracking dye PKH26 to follow the fate of HIV-infected human PBMC in SCID mice: An In Vivo model for AIDS drug development: PAUL L. BLACK, DENNIS D. BROUD, OWEN L. WOOD, GARY P. GOLDBERG, and MICHAEL A. USSERY. U.S.F.D.A., Rockville, Maryland, USA

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Antiviral activity of the protease inhib

Antiviral activity of the protease inhibitor KNI-272 in vivo in the HIV-infected HuPBMC-SCID mouse model: Michael A. Ussery, Owen L. Wood, Dennis D. Broud, Matthew Bacho, Steven C. Kunder, Susan Papermaster, Yoshiaki Kiso1, and Paul L. Black. U.S.F.D.A., Rockville, MD, USA, and 1 Kyoto Pharmaceutical University, Kyoto, Japan

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Antiviral agents reduce viral load and d

Antiviral agents reduce viral load and delay the detection of infected cells in vivo in the HIV-infected Hu-PBMC SCID mouse model: Michael A. Ussery1, Dennis D. Broud1, Owen L. Wood1, Steven C. Kunder1, Paul L. Black1, Peter J. Dailey2, Judith C. Wilber2, Limei Yang3, Michael Piatek, Jr.3, and Jeffery D. Lifson3. 1FDA, Rockville, MD 20857; 2Chiron Corp., Emeryville, CA 94668; and 3Genelabs Technologies, Inc, Redwood City, CA 94063

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 85 KB